Plain-English translation of NCT07749417 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying a new way to monitor kidney function during and after heart surgery or contrast-enhanced imaging using a special fluorescent tracer and a transcutaneous monitoring system. The goal is to catch kidney injury earlier—before standard blood tests show a problem—so doctors can intervene sooner. This could help prevent serious complications in patients undergoing heart procedures.
Kidney injury after heart surgery or contrast imaging is common and can develop quickly, but standard blood tests often detect it too late. This study aims to fill that gap by validating a real-time monitoring approach that could give doctors a head start in protecting patients' kidney health.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive an intravenous injection of a fluorescent tracer before your heart surgery or contrast imaging. A special monitoring device will then measure your kidney function continuously throughout your procedure and recovery period. Researchers will collect your medical information, lab results, and imaging findings to track how your kidney function changes and compare these changes to standard diagnostic methods.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
China